Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Franck E. Nicolini, Stéphanie Dulucq, Lisa Boureau, +30

Clinical Cancer Research

[Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP].

C. Larroche, Fabrice Bruneel, Marc André, +5

PubMed

ImmunohematologyImmunodeficienciesHigh-dose Gamma-globulinsImmunologyPathology +18

Impact of Inhaled Nitric Oxide on Platelet Aggregation and Fibrinolysis in Rats with Endotoxic Lung Injury

Nathalie Kermarrec, Patricia Zunic, Sadek Béloucif, +3

American Journal of Respiratory and Critical Care Medicine

Acute Lung InjuryLung InflammationPlatelet AggregationOxidative StressInflammation +21

Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.

L Fouillard, J.P. Laporte, Myriam Labopin, +18

Journal of Clinical Oncology

[Saccharomyces boulardii fungemia. Apropos of a case].

Patricia Zunic, Jérôme Lacotte, M. Pégoix, +4

PubMed

MedicineClinical MycologyPathogenesisPathology

Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes

Laura Polivka, Marine Madrange, C. Bulaï Livideanu, +53

Journal of Allergy and Clinical Immunology

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Murielle Roussel, Valérie Lauwers‐Cancès, Margaret Macro, +56

Blood

Evaluation of quantitative FTD- Pneumocystis jirovecii kit for Pneumocystis infection diagnosis

Gautier Hoarau, Solène Le Gal, Patricia Zunic, +4

Diagnostic Microbiology and Infectious Disease

MicrobiologyDiagnosisMedicinePneumocystis Infection Diagnosis

Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial

Stéphanie Dulucq, Franck E. Nicolini, Delphine Réa, +27

Haematologica

Mixed-phenotype Acute LeukemiaStim2 TrialLate Molecular RecurrencesPathologyPharmacotherapy +16

Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real‐world: The retrospective IMAGE study

Olivier Decaux, Jean Fontan, Aurore Perrot, +21

European Journal Of Haematology